Analysts predicted new obesity medicines would be blockbusters. Now they’re raising their forecasts

United States News News

Analysts predicted new obesity medicines would be blockbusters. Now they’re raising their forecasts
United States Latest News,United States Headlines
  • 📰 CNBC
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 72%

Guggenheim analyst Seamus Fernandez said the total addressable market for GLP-1 drugs like Ozempic and Wegovy could balloon to $150 billion to $200 billion.

As new weight loss medications garnered buzz last year, analysts' forecasts signaled these drugs would be blockbusters, with some of the highest estimates calling for peak sales of at least $100 billion. In recent days, the expectations are moving higher still. The initial projections were made before Wall Street saw the results of Novo Nordisk's Select trial in August.

mountain Dexcom shares have struggled in recent weeks. Plovanic's view is based on many factors, but he mentioned that the costs of GLP-1 medications are high and in the real world — not clinical trials — there is a large drop-off rate for people taking the drugs.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Corporate bankruptcies on pace for worst year since 2010, but there is a hitch, Guggenheim saysCorporate bankruptcies on pace for worst year since 2010, but there is a hitch, Guggenheim saysCorporate distress is on the rise due to higher interest rates, but companies also recently earned a record amount on cash, Treasury and agency debt...
Read more »

Rate hikes cut both ways as corporate bankruptcies head for worst year since 2010, Guggenheim saysRate hikes cut both ways as corporate bankruptcies head for worst year since 2010, Guggenheim saysCorporate distress is on the rise due to higher interest rates, but companies also recently earned a record amount on cash, Treasury and agency debt...
Read more »

Analysts left Microsoft's AI event feeling even more bullish about the stockAnalysts left Microsoft's AI event feeling even more bullish about the stockComments from a recent Microsoft event are giving Wall Street more reasons to get bullish on the technology giant.
Read more »

Ethereum's active addresses second-highest in history: analystsEthereum's active addresses second-highest in history: analystsSantiment reports Ethereum's daily active addresses at the second-highest ever as potential volatility and recovery is expected. Ethereum faces market instability but remains vital in DeFi and smart contracts.
Read more »

NFL analysts on concern about Eagles, Jalen Hurts: R-E-L-A-XNFL analysts on concern about Eagles, Jalen Hurts: R-E-L-A-XNJ Advance Media asked Amazon Prime's 'Thursday Night Football' analysts about if there should be any worries surrounding the Eagles after their close Week 1 win over the New England Patriots.
Read more »

Analysts Eye Ethereum's Hammer Candle as Bullish Turnaround IndicatorAnalysts Eye Ethereum's Hammer Candle as Bullish Turnaround IndicatorAmid a challenging month marked by four consecutive weeks of falling prices, Ethereum may be signaling a bullish reversal
Read more »



Render Time: 2025-03-30 02:03:46